Completed Phase 1 trials in Slovakia: Trial Insights

Filters: Phase: Phase 1 Status: Completed Country / region: Slovakia Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2005	2
2006	1
2007	3
2008	2
2009	3
2010	5
2011	3
2012	1
2013	4
2014	1
2015	2
2017	6
2018	2
2019	3
2020	4
2021	2
2022	1
2023	6

Trials by status
Category	Trials
Completed	52

Top lead sponsors
Category	Trials
Hoffmann-La Roche	7
Novo Nordisk A/S	7
Pfizer	5
GlaxoSmithKline	3
Astellas Pharma Inc	2
Boehringer Ingelheim	2
Eli Lilly and Company	2
Takeda	2
Vertex Pharmaceuticals Incorporated	2
pharmaand GmbH	2

Top conditions
Category	Trials
Diabetes Mellitus, Type 2	7
Diabetes Mellitus	3
Lymphoma, Follicular	3
Schizophrenia	3
Colitis, Ulcerative	2
Liver Diseases	2
Neoplasms	2
Alzheimer Disease	1
Arthritis	1
Arthritis, Juvenile	1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

A Study About Fazirsiran in People With and Without Liver Problems NCT05891158Phase 1CompletedTakedaStarted 2023
A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function NCT05917938Phase 1CompletedNovo Nordisk A/SStarted 2023
A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body NCT05564104Phase 1CompletedNovo Nordisk A/SStarted 2023
A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis NCT05939947Phase 1CompletedAlentis Therapeutics AGStarted 2023
Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects NCT05790304Phase 1CompletedAstraZenecaStarted 2023
A Phase 1 Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function NCT05706623Phase 1CompletedVectivBio AGStarted 2023
A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906 NCT05296733Phase 1CompletedBoehringer IngelheimStarted 2022
A Study of LY3361237 in Participants With Psoriasis NCT04975295Phase 1CompletedEli Lilly and CompanyStarted 2021
Safety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment NCT04791553Phase 1CompletedSK Life Science, Inc.Started 2021
A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver Disease NCT04597697Phase 1CompletedNovo Nordisk A/SStarted 2020
A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis NCT04594928Phase 1CompletedLakefront Biotherapeutics NVStarted 2020
A Study to Investigate the Effect of Impaired Hepatic Function on the Pharmacokinetics of Entrectinib in Volunteers With Different Levels of Hepatic Function NCT04226833Phase 1CompletedHoffmann-La RocheStarted 2020
A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT NCT04193436Phase 1CompletedPfizerStarted 2020
Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer NCT03994211Phase 1CompletedBeiGeneStarted 2019
Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives NCT03954366Phase 1Completedpharmaand GmbHStarted 2019
An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage NCT03890809Phase 1CompletedBristol-Myers SquibbStarted 2019
PK Study in Subjects With Severe Hepatic Impairment NCT03664544Phase 1CompletedShionogiStarted 2018
Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor NCT03521037Phase 1Completedpharmaand GmbHStarted 2018
Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment NCT03309202Phase 1CompletedPfizerStarted 2017
Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care NCT03456349Phase 1CompletedNxera Pharma UK LimitedStarted 2017
A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954 NCT03277274Phase 1CompletedTakedaStarted 2017
This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated NCT03165240Phase 1CompletedBoehringer IngelheimStarted 2017
Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function. NCT03212131Phase 1CompletedNovo Nordisk A/SStarted 2017
A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers NCT03207425Phase 1CompletedEnanta Pharmaceuticals, IncStarted 2017
Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib NCT02621047Phase 1CompletedHoffmann-La RocheStarted 2015

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory